Andy Neely is Cambridge’s Pro-Vice-Chancellor for Enterprise and Business Relations, a role which oversees the University’s activities in innovation, commercialisation and entrepreneurship. After six months in the role, he sees an entrepreneurial ecosystem that may appear complex at first – but a deeper examination reveals a combination of knowledge, expertise, support and infrastructure that makes Cambridge one of the most enterprising and entrepreneurial cities in the world.
When it comes to starting social enterprises, Paul Tracey and Neil Stott would love "to see a thousand flowers bloom". But doing good for society isn’t as straightforward as it sounds and even the best ideas can fail. Their research aims to understand the elements that are needed to help social ventures thrive.
An international collaboration between universities and industry will further develop carbon capture and storage technology – one of the best hopes for drastically reducing carbon emissions – so that it can be deployed in a wider range of sites around the world.
Dr Tim Minshall has been appointed as the inaugural Dr John C Taylor Professor of Innovation at the University of Cambridge, a new post that will build on the University’s strengths in science, engineering and entrepreneurship. Dr Minshall, who is currently Reader in Technology & Innovation Management in the Department of Engineering and Fellow of Churchill College, will take up his new post on 1 October.
In this piece for The Conversation, Carlos López-Gómez from Cambridge's Institute for Manufacturing, discusses the role that small and medium-sized businesses might play in a post-Brexit economy.
Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials.
Celebrating young sustainability innovators
Are strict IP policies harming the development of sustainable technologies? In this article for The Conversation, Frank Tietze from the Institute for Manufacturing investigates how the open source approach taken by companies such as Tesla may help the economy and the planet.
A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease.